“It’s particularly gratifying to have followed a patient in the trial for over 18 months where their tumour burden has been reduced to zero. For such a late-stage patient, having a chemo-free alternative could mean a very real difference to their quality of life, she added”.
WOWeeeee !!!!
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene Presents New PD1-Vaxx Data at the 2022 WCLC
IMU
imugene limited
Add to My Watchlist
3.13%
!
31.0¢

Ann: Imugene Presents New PD1-Vaxx Data at the 2022 WCLC, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
-0.010(3.13%) |
Mkt cap ! $70.31M |
Open | High | Low | Value | Volume |
31.5¢ | 31.5¢ | 30.5¢ | $196.4K | 629.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 97975 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 20504 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 138807 | 0.310 |
15 | 340341 | 0.305 |
28 | 268369 | 0.300 |
7 | 69302 | 0.295 |
9 | 134815 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 21627 | 8 |
0.320 | 530884 | 8 |
0.325 | 40719 | 4 |
0.330 | 55480 | 2 |
0.335 | 41738 | 4 |
Last trade - 10.34am 23/07/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |